Bleichroeder LP - Dec 13, 2023 Form 4 Insider Report for SCIENTIFIC INDUSTRIES INC (SCND)

Role
10%+ Owner
Signature
Michael M. Kellen, Chairman and CO-CEO of Bleichroeder LP
Stock symbol
SCND
Transactions as of
Dec 13, 2023
Transactions value $
$1,200,000
Form type
4
Date filed
12/15/2023, 04:39 PM
Previous filing
Dec 4, 2023
Next filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCND Common Stock Purchase $1.2M +600K +99.44% $2.00 1.2M Dec 13, 2023 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCND Warrants to Purchase Common Stock Other -279K -100% 0 Dec 13, 2023 Common Stock 279K $9.50 See footnote F2, F3
transaction SCND Warrants to Purchase Common Stock Other +279K 279K Dec 13, 2023 Common Stock 279K $2.50 See footnote F2, F3
transaction SCND Warrants to Purchase Common Stock Other -22.7K -100% 0 Dec 13, 2023 Common Stock 22.7K $5.50 See footnote F2, F3
transaction SCND Warrants to Purchase Common Stock Other +22.7K 22.7K Dec 13, 2023 Common Stock 22.7K $2.50 See footnote F2, F3
transaction SCND Warrants to Purchase Common Stock Purchase +960K 960K Dec 13, 2023 Common Stock 960K $2.50 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 13, 2023, 21 April Fund, Ltd., 21 April Fund, LP and Scientific Industries Inc. (the "Issuer") entered into an agreement (the "Securities Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer, for an aggregate purchase price of $1,200,000, 600,000 shares of Common Stock and warrants to acquire 960,000 shares of Common Stock at an exercise price of $2.50 per share.
F2 This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.
F3 On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants.